Catalyst Wire Dossier Catalyst Wire Dossier

GR1014 Cutaneous Gel

· Graegis Pharmaceuticals Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GR1014 Cutaneous Gel, covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer [Phase 2]

See pricing